SBIO vs. THNR ETF Comparison
Comparison of ALPS Medical Breakthroughs ETF (SBIO) to Amplify Weight Loss Drug & Treatment ETF (THNR)
SBIO
ALPS Medical Breakthroughs ETF
SBIO Description
The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.
Grade (RS Rating)
Last Trade
$37.19
Average Daily Volume
8,401
83
THNR
Amplify Weight Loss Drug & Treatment ETF
THNR Description
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.Grade (RS Rating)
Last Trade
$23.22
Average Daily Volume
2,604
15
Performance
| Period | SBIO | THNR |
|---|---|---|
| 30 Days | -5.42% | -11.49% |
| 60 Days | -4.19% | -15.44% |
| 90 Days | 2.30% | -16.31% |
| 12 Months | 47.72% |
1 Overlapping Holdings
| Symbol | Grade | Weight in SBIO | Weight in THNR | Overlap | |
|---|---|---|---|---|---|
| ALT | C | 0.37% | 0.27% | 0.27% |
SBIO Overweight 82 Positions Relative to THNR
| Symbol | Grade | Weight | |
|---|---|---|---|
| CORT | B | 3.66% | |
| KRYS | C | 3.39% | |
| RNA | C | 3.29% | |
| ACLX | C | 3.19% | |
| ALKS | C | 3.15% | |
| CRNX | B | 2.95% | |
| IMVT | F | 2.66% | |
| DNLI | D | 2.36% | |
| MRUS | F | 2.21% | |
| AGIO | C | 2.05% | |
| PTCT | B | 2.02% | |
| XENE | D | 2.01% | |
| VRNA | A | 1.98% | |
| FOLD | F | 1.95% | |
| EWTX | C | 1.92% | |
| ACAD | C | 1.89% | |
| VERA | C | 1.82% | |
| ZLAB | C | 1.79% | |
| VCEL | A | 1.73% | |
| PTGX | D | 1.61% | |
| CGON | F | 1.57% | |
| IDYA | F | 1.53% | |
| GERN | C | 1.48% | |
| MIRM | B | 1.47% | |
| KROS | D | 1.4% | |
| LBPH | A | 1.4% | |
| AKRO | C | 1.32% | |
| MNKD | B | 1.26% | |
| IRON | B | 1.21% | |
| GLPG | F | 1.19% | |
| TARS | C | 1.16% | |
| IMCR | C | 1.07% | |
| CLDX | D | 1.06% | |
| ARVN | F | 1.06% | |
| BCRX | D | 0.99% | |
| XNCR | B | 0.98% | |
| RCUS | F | 0.95% | |
| NTLA | F | 0.94% | |
| SNDX | F | 0.93% | |
| SPRY | C | 0.88% | |
| VRDN | D | 0.84% | |
| KURA | F | 0.83% | |
| DAWN | D | 0.82% | |
| AUPH | C | 0.78% | |
| PHVS | D | 0.76% | |
| APLT | B | 0.72% | |
| COGT | D | 0.69% | |
| ETNB | D | 0.57% | |
| LQDA | F | 0.54% | |
| PLRX | D | 0.53% | |
| PRTA | F | 0.52% | |
| ERAS | C | 0.51% | |
| REPL | C | 0.5% | |
| IRWD | F | 0.44% | |
| AVXL | B | 0.42% | |
| ANNX | F | 0.4% | |
| MLYS | F | 0.39% | |
| OLMA | F | 0.37% | |
| ANAB | F | 0.36% | |
| FLGT | F | 0.35% | |
| ALLO | F | 0.35% | |
| CELC | F | 0.34% | |
| YMAB | F | 0.34% | |
| URGN | F | 0.34% | |
| SVRA | F | 0.34% | |
| FULC | F | 0.33% | |
| TBPH | B | 0.32% | |
| FDMT | F | 0.31% | |
| GHRS | B | 0.31% | |
| ARCT | F | 0.31% | |
| AURA | C | 0.3% | |
| ALEC | F | 0.28% | |
| CMPS | F | 0.23% | |
| ACIU | D | 0.22% | |
| VNDA | C | 0.2% | |
| ITOS | F | 0.19% | |
| STRO | F | 0.17% | |
| ALDX | D | 0.17% | |
| ZNTL | D | 0.17% | |
| ENTA | F | 0.14% | |
| INZY | F | 0.12% | |
| HLVX | F | 0.06% |
SBIO: Top Represented Industries & Keywords
THNR: Top Represented Industries & Keywords
Compare ETFs
